| 0 |
SARS-COV-2 SEPSIS |
13 |
0.3611 |
| 1 |
CUTANEOUS T-CELL LYMPHOMA STAGE I |
9 |
0.2500 |
| 2 |
HAEMOPHILUS BACTERAEMIA |
6 |
0.1224 |
| 3 |
SEPTUM PELLUCIDUM AGENESIS |
6 |
0.1000 |
| 4 |
CT HYPOTENSION COMPLEX |
1 |
0.1000 |
| 5 |
GASTROINTESTINAL DILATION PROCEDURE |
3 |
0.0638 |
| 6 |
TRANSIENT APHASIA |
8 |
0.0611 |
| 7 |
ANISOCHROMIA |
1 |
0.0556 |
| 8 |
LYMPHOID TISSUE HYPOPLASIA |
8 |
0.0523 |
| 9 |
THYMUS HYPOPLASIA |
8 |
0.0460 |
| 10 |
ACQUIRED METHAEMOGLOBINAEMIA |
2 |
0.0455 |
| 11 |
CEREBRAL MICROEMBOLISM |
1 |
0.0455 |
| 12 |
PRECURSOR B-LYMPHOBLASTIC LYMPHOMA |
2 |
0.0435 |
| 13 |
MYOCARDIAL CALCIFICATION |
5 |
0.0427 |
| 14 |
TUMOUR LYSIS SYNDROME |
364 |
0.0413 |
| 15 |
BLOOD BETA-D-GLUCAN POSITIVE |
1 |
0.0385 |
| 16 |
PSEUDOHYPONATRAEMIA |
5 |
0.0365 |
| 17 |
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA STAGE IV |
1 |
0.0357 |
| 18 |
STOMA SITE CELLULITIS |
2 |
0.0351 |
| 19 |
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY |
8 |
0.0343 |
| 20 |
METHAEMOGLOBINAEMIA |
74 |
0.0319 |
| 21 |
ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES |
8 |
0.0273 |
| 22 |
SUBDURAL HYGROMA |
8 |
0.0263 |
| 23 |
MYELOBLAST COUNT INCREASED |
2 |
0.0260 |
| 24 |
URATE NEPHROPATHY |
3 |
0.0259 |
| 25 |
RENAL ISCHAEMIA |
14 |
0.0256 |
| 26 |
CONJUNCTIVAL PIGMENTATION |
1 |
0.0250 |
| 27 |
TRANSFUSION-RELATED CIRCULATORY OVERLOAD |
6 |
0.0248 |
| 28 |
EAR INFECTION STAPHYLOCOCCAL |
3 |
0.0246 |
| 29 |
CENTRAL-ALVEOLAR HYPOVENTILATION |
1 |
0.0222 |
| 30 |
COOMBS NEGATIVE HAEMOLYTIC ANAEMIA |
4 |
0.0205 |
| 31 |
HYPOFIBRINOGENAEMIA |
20 |
0.0202 |
| 32 |
ALLERGIC TRANSFUSION REACTION |
3 |
0.0199 |
| 33 |
CELL-MEDIATED CYTOTOXICITY |
1 |
0.0196 |
| 34 |
CONGENITAL HIATUS HERNIA |
4 |
0.0175 |
| 35 |
DEVICE RELATED BACTERAEMIA |
5 |
0.0161 |
| 36 |
LARYNGEAL INFLAMMATION |
3 |
0.0160 |
| 37 |
ANTI-HBS ANTIBODY POSITIVE |
1 |
0.0156 |
| 38 |
ANTACID THERAPY |
2 |
0.0154 |
| 39 |
CAPILLARY PERMEABILITY INCREASED |
1 |
0.0154 |
| 40 |
SKIN LESION INFLAMMATION |
2 |
0.0152 |
| 41 |
NASAL FLARING |
2 |
0.0149 |
| 42 |
DISSEMINATED ASPERGILLOSIS |
7 |
0.0148 |
| 43 |
HYPERPHOSPHATAEMIA |
31 |
0.0144 |
| 44 |
BLOOD URIC ACID DECREASED |
7 |
0.0144 |
| 45 |
CORYNEBACTERIUM TEST POSITIVE |
1 |
0.0141 |
| 46 |
MYELOMA CAST NEPHROPATHY |
2 |
0.0141 |
| 47 |
ADENOVIRUS REACTIVATION |
2 |
0.0139 |
| 48 |
IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME |
2 |
0.0132 |
| 49 |
CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT |
9 |
0.0129 |
| 50 |
MYOCARDIAL NECROSIS |
3 |
0.0129 |
| 51 |
BLOOD PHOSPHORUS INCREASED |
34 |
0.0124 |
| 52 |
BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA |
1 |
0.0123 |
| 53 |
BLOOD URIC ACID ABNORMAL |
5 |
0.0123 |
| 54 |
DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV |
4 |
0.0122 |
| 55 |
BLADDER OUTLET OBSTRUCTION |
2 |
0.0121 |
| 56 |
BLASTOCYSTIS INFECTION |
1 |
0.0115 |
| 57 |
HAEMOPERITONEUM |
9 |
0.0112 |
| 58 |
CARDIAC SEPTAL DEFECT |
8 |
0.0111 |
| 59 |
NECROTISING COLITIS |
14 |
0.0110 |
| 60 |
ACINETOBACTER BACTERAEMIA |
2 |
0.0106 |
| 61 |
ENTEROCOCCAL BACTERAEMIA |
11 |
0.0104 |
| 62 |
APPENDICOLITH |
4 |
0.0103 |
| 63 |
SLEEP DISORDER THERAPY |
2 |
0.0101 |
| 64 |
BACILLUS TEST POSITIVE |
1 |
0.0101 |
| 65 |
BLOOD ERYTHROPOIETIN INCREASED |
1 |
0.0101 |
| 66 |
ASPERGILLUS TEST POSITIVE |
3 |
0.0097 |
| 67 |
MALIGNANT MELANOMA STAGE 0 |
2 |
0.0096 |
| 68 |
MYCOBACTERIUM CHELONAE INFECTION |
7 |
0.0095 |
| 69 |
ANALGESIC THERAPY |
3 |
0.0093 |
| 70 |
CARDIOVASCULAR INSUFFICIENCY |
15 |
0.0092 |
| 71 |
PSEUDOMONAL SEPSIS |
16 |
0.0091 |
| 72 |
BLOOD METHAEMOGLOBIN PRESENT |
1 |
0.0090 |
| 73 |
ACID BASE BALANCE ABNORMAL |
2 |
0.0089 |
| 74 |
COAGULATION FACTOR VII LEVEL DECREASED |
1 |
0.0088 |
| 75 |
DRUG THERAPY |
3 |
0.0088 |
| 76 |
TUMOUR FLARE |
6 |
0.0088 |
| 77 |
CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME |
1 |
0.0081 |
| 78 |
CRUSH INJURY |
1 |
0.0078 |
| 79 |
BACTEROIDES INFECTION |
2 |
0.0077 |
| 80 |
CYTOTOXIC OEDEMA |
2 |
0.0075 |
| 81 |
LABILE HYPERTENSION |
2 |
0.0072 |
| 82 |
PARAINFLUENZAE VIRUS INFECTION |
11 |
0.0072 |
| 83 |
ANTICOAGULANT THERAPY |
2 |
0.0070 |
| 84 |
ABSCESS STERILE |
1 |
0.0068 |
| 85 |
CAECITIS |
3 |
0.0067 |
| 86 |
CYTOKINE RELEASE SYNDROME |
133 |
0.0066 |
| 87 |
QUADRIPARESIS |
11 |
0.0066 |
| 88 |
ERYTHROPOIESIS ABNORMAL |
2 |
0.0065 |
| 89 |
ACUTE PHOSPHATE NEPHROPATHY |
1 |
0.0064 |
| 90 |
VASCULAR COMPRESSION |
2 |
0.0063 |
| 91 |
ENTEROCOCCAL SEPSIS |
5 |
0.0062 |
| 92 |
ACTION TREMOR |
1 |
0.0062 |
| 93 |
ADNEXA UTERI CYST |
1 |
0.0061 |
| 94 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
36 |
0.0061 |
| 95 |
GASTROENTERITIS BACTERIAL |
2 |
0.0060 |
| 96 |
BLOOD LACTATE DEHYDROGENASE DECREASED |
2 |
0.0060 |
| 97 |
CORONAVIRUS PNEUMONIA |
1 |
0.0060 |
| 98 |
BLOOD URIC ACID INCREASED |
34 |
0.0059 |
| 99 |
ENTEROVIRUS INFECTION |
5 |
0.0058 |
| 100 |
SECONDARY IMMUNODEFICIENCY |
7 |
0.0058 |
| 101 |
BASE EXCESS DECREASED |
1 |
0.0056 |
| 102 |
DIFFERENTIATION SYNDROME |
4 |
0.0054 |
| 103 |
ENTEROCOLITIS INFECTIOUS |
5 |
0.0054 |
| 104 |
CEREBRAL HAEMATOMA |
18 |
0.0054 |
| 105 |
BLOOD FIBRINOGEN DECREASED |
6 |
0.0053 |
| 106 |
ADMINISTRATION SITE REACTION |
2 |
0.0052 |
| 107 |
FEBRILE BONE MARROW APLASIA |
22 |
0.0052 |
| 108 |
LOWER RESPIRATORY TRACT INFECTION FUNGAL |
2 |
0.0051 |
| 109 |
BIOPSY KIDNEY ABNORMAL |
1 |
0.0051 |
| 110 |
DEVICE RELATED THROMBOSIS |
5 |
0.0051 |
| 111 |
CHEST WALL ABSCESS |
1 |
0.0051 |
| 112 |
ADENOVIRAL HAEMORRHAGIC CYSTITIS |
1 |
0.0048 |
| 113 |
CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION |
1 |
0.0048 |
| 114 |
CHLOROMA |
2 |
0.0047 |
| 115 |
HAEMOLYTIC ANAEMIA |
41 |
0.0046 |
| 116 |
CARDIOMYOPATHY ACUTE |
1 |
0.0046 |
| 117 |
ABDOMINAL MASS |
12 |
0.0045 |
| 118 |
REFUSAL OF TREATMENT BY RELATIVE |
2 |
0.0044 |
| 119 |
HYPERURICAEMIA |
18 |
0.0044 |
| 120 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
15 |
0.0044 |
| 121 |
B-CELL SMALL LYMPHOCYTIC LYMPHOMA |
1 |
0.0043 |
| 122 |
ANGIOSARCOMA |
2 |
0.0043 |
| 123 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
4 |
0.0043 |
| 124 |
CENTRAL NERVOUS SYSTEM HAEMORRHAGE |
2 |
0.0043 |
| 125 |
SYSTEMIC MYCOSIS |
5 |
0.0043 |
| 126 |
BONE MARROW NECROSIS |
1 |
0.0043 |
| 127 |
ESCHERICHIA BACTERAEMIA |
10 |
0.0042 |
| 128 |
ANAPLASTIC LARGE-CELL LYMPHOMA |
1 |
0.0042 |
| 129 |
ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING |
1 |
0.0042 |
| 130 |
KLEBSIELLA BACTERAEMIA |
4 |
0.0042 |
| 131 |
NEUTROPENIC INFECTION |
4 |
0.0042 |
| 132 |
BACTERIAL DISEASE CARRIER |
3 |
0.0041 |
| 133 |
CONTINUOUS HAEMODIAFILTRATION |
4 |
0.0041 |
| 134 |
HYPERTRIGLYCERIDAEMIA |
23 |
0.0039 |
| 135 |
NEUTROPENIC SEPSIS |
28 |
0.0039 |
| 136 |
HAEMOLYSIS |
30 |
0.0039 |
| 137 |
B-CELL APLASIA |
1 |
0.0039 |
| 138 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
10 |
0.0039 |
| 139 |
NEUTROPENIC COLITIS |
8 |
0.0039 |
| 140 |
PRODUCT INEFFECTIVE |
3 |
0.0038 |
| 141 |
RESPIRATORY TRACT INFECTION FUNGAL |
2 |
0.0038 |
| 142 |
GUILLAIN-BARRE SYNDROME |
18 |
0.0037 |
| 143 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
103 |
0.0036 |
| 144 |
PSEUDOMONAS INFECTION |
31 |
0.0036 |
| 145 |
GASTRIC DILATATION |
6 |
0.0036 |
| 146 |
RHINOVIRUS INFECTION |
14 |
0.0036 |
| 147 |
INTRAVASCULAR HAEMOLYSIS |
2 |
0.0036 |
| 148 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
3 |
0.0036 |
| 149 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
26 |
0.0035 |
| 150 |
VASOCONSTRICTION |
3 |
0.0034 |
| 151 |
CATHETER SITE CELLULITIS |
1 |
0.0034 |
| 152 |
FOLLICULAR LYMPHOMA |
3 |
0.0034 |
| 153 |
ENGRAFTMENT SYNDROME |
2 |
0.0034 |
| 154 |
CAPILLARY LEAK SYNDROME |
7 |
0.0034 |
| 155 |
AORTIC VALVE STENOSIS |
6 |
0.0034 |
| 156 |
PNEUMOCYSTIS JIROVECII INFECTION |
4 |
0.0033 |
| 157 |
PLASMA CELL LEUKAEMIA |
2 |
0.0033 |
| 158 |
SUPERIOR VENA CAVA SYNDROME |
2 |
0.0033 |
| 159 |
FEBRILE NEUTROPENIA |
217 |
0.0033 |
| 160 |
STAPHYLOCOCCAL BACTERAEMIA |
14 |
0.0032 |
| 161 |
URINARY TRACT INFECTION ENTEROCOCCAL |
3 |
0.0032 |
| 162 |
SYSTEMIC CANDIDA |
8 |
0.0032 |
| 163 |
HYPERCHLORAEMIA |
2 |
0.0031 |
| 164 |
COAGULATION FACTOR V LEVEL DECREASED |
1 |
0.0031 |
| 165 |
ILEAL PERFORATION |
2 |
0.0030 |
| 166 |
HYPERBILIRUBINAEMIA |
31 |
0.0030 |
| 167 |
ACUTE LEFT VENTRICULAR FAILURE |
2 |
0.0030 |
| 168 |
BLOOD LACTATE DEHYDROGENASE ABNORMAL |
2 |
0.0029 |
| 169 |
BRAIN STEM INFARCTION |
3 |
0.0029 |
| 170 |
MUCOUS MEMBRANE DISORDER |
4 |
0.0029 |
| 171 |
GALLBLADDER ENLARGEMENT |
3 |
0.0028 |
| 172 |
CARDIAC ENZYMES INCREASED |
2 |
0.0028 |
| 173 |
ABSCESS BACTERIAL |
1 |
0.0028 |
| 174 |
OVARIAN MASS |
2 |
0.0027 |
| 175 |
DISSEMINATED INTRAVASCULAR COAGULATION |
38 |
0.0027 |
| 176 |
HAEMOGLOBINURIA |
3 |
0.0027 |
| 177 |
SERONEGATIVE ARTHRITIS |
3 |
0.0026 |
| 178 |
COAGULATION TEST ABNORMAL |
2 |
0.0026 |
| 179 |
OSTEOCHONDROSIS |
3 |
0.0026 |
| 180 |
APLASIA |
5 |
0.0026 |
| 181 |
CENTRAL NERVOUS SYSTEM LEUKAEMIA |
1 |
0.0025 |
| 182 |
STREPTOCOCCAL SEPSIS |
3 |
0.0025 |
| 183 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
12 |
0.0025 |
| 184 |
HAPTOGLOBIN DECREASED |
2 |
0.0025 |
| 185 |
SUDDEN HEARING LOSS |
5 |
0.0025 |
| 186 |
LINEAR IGA DISEASE |
4 |
0.0024 |
| 187 |
URINARY TRACT INFECTION BACTERIAL |
6 |
0.0024 |
| 188 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
12 |
0.0024 |
| 189 |
PROCEDURAL HYPOTENSION |
2 |
0.0024 |
| 190 |
CORONA VIRUS INFECTION |
1 |
0.0023 |
| 191 |
PULMONARY CAVITATION |
2 |
0.0023 |
| 192 |
HYPERLEUKOCYTOSIS |
2 |
0.0023 |
| 193 |
INTESTINAL DILATATION |
3 |
0.0022 |
| 194 |
BIOPSY BONE MARROW ABNORMAL |
1 |
0.0022 |
| 195 |
URINE ABNORMALITY |
10 |
0.0022 |
| 196 |
NEUROLOGICAL DECOMPENSATION |
5 |
0.0022 |
| 197 |
BLOOD PHOSPHORUS ABNORMAL |
1 |
0.0021 |
| 198 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
6 |
0.0021 |
| 199 |
DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY |
2 |
0.0021 |
| 200 |
CELL MARKER INCREASED |
1 |
0.0021 |
| 201 |
CARDIAC VALVE VEGETATION |
1 |
0.0021 |
| 202 |
HAEMATOLOGICAL INFECTION |
5 |
0.0020 |
| 203 |
DUODENAL PERFORATION |
2 |
0.0020 |
| 204 |
CYTOMEGALOVIRUS VIRAEMIA |
9 |
0.0020 |
| 205 |
MANTLE CELL LYMPHOMA |
3 |
0.0020 |
| 206 |
FUNGAEMIA |
3 |
0.0019 |
| 207 |
HYPOPERFUSION |
2 |
0.0019 |
| 208 |
URINE KETONE BODY PRESENT |
3 |
0.0019 |
| 209 |
STAPHYLOCOCCUS TEST POSITIVE |
4 |
0.0019 |
| 210 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
5 |
0.0019 |
| 211 |
HYPERCALCAEMIA |
23 |
0.0019 |
| 212 |
ENTEROCOCCAL INFECTION |
9 |
0.0019 |
| 213 |
ACUTE LEUKAEMIA |
3 |
0.0019 |
| 214 |
BLOOD GASES ABNORMAL |
1 |
0.0019 |
| 215 |
STREPTOCOCCAL BACTERAEMIA |
2 |
0.0018 |
| 216 |
HAEMODYNAMIC INSTABILITY |
14 |
0.0018 |
| 217 |
NOSOCOMIAL INFECTION |
4 |
0.0018 |
| 218 |
BLOOD MAGNESIUM ABNORMAL |
1 |
0.0018 |
| 219 |
BRAIN SCAN ABNORMAL |
1 |
0.0018 |
| 220 |
CATHETER SITE INFLAMMATION |
1 |
0.0018 |
| 221 |
DISTRIBUTIVE SHOCK |
4 |
0.0018 |
| 222 |
OXYGEN SATURATION ABNORMAL |
5 |
0.0018 |
| 223 |
HYPERKALAEMIA |
61 |
0.0017 |
| 224 |
CELLULITIS ORBITAL |
1 |
0.0017 |
| 225 |
TOXIC EPIDERMAL NECROLYSIS |
26 |
0.0017 |
| 226 |
VENTRICULAR FIBRILLATION |
19 |
0.0017 |
| 227 |
FEBRILE INFECTION |
2 |
0.0017 |
| 228 |
HEPATOCELLULAR INJURY |
24 |
0.0017 |
| 229 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
26 |
0.0016 |
| 230 |
CEREBRAL ASPERGILLOSIS |
1 |
0.0016 |
| 231 |
BLOOD BILIRUBIN DECREASED |
1 |
0.0016 |
| 232 |
MALIGNANT MELANOMA IN SITU |
2 |
0.0016 |
| 233 |
INTRA-ABDOMINAL HAEMATOMA |
2 |
0.0016 |
| 234 |
BILIARY TRACT INFECTION |
1 |
0.0016 |
| 235 |
VENOOCCLUSIVE DISEASE |
4 |
0.0016 |
| 236 |
BLOOD BICARBONATE DECREASED |
3 |
0.0016 |
| 237 |
ABDOMINAL COMPARTMENT SYNDROME |
1 |
0.0016 |
| 238 |
ENDOCRINE DISORDER |
2 |
0.0016 |
| 239 |
DIFFUSE LARGE B-CELL LYMPHOMA |
12 |
0.0016 |
| 240 |
METABOLIC DISORDER |
9 |
0.0015 |
| 241 |
BACTERIAL SEPSIS |
5 |
0.0015 |
| 242 |
C-REACTIVE PROTEIN DECREASED |
1 |
0.0015 |
| 243 |
ANISOCYTOSIS |
1 |
0.0015 |
| 244 |
BLOOD LACTIC ACID INCREASED |
8 |
0.0015 |
| 245 |
POLYDIPSIA |
6 |
0.0015 |
| 246 |
CHRONIC MYELOMONOCYTIC LEUKAEMIA |
1 |
0.0015 |
| 247 |
HYPOXIA |
53 |
0.0015 |
| 248 |
BRONCHITIS VIRAL |
1 |
0.0015 |
| 249 |
LYMPHOPENIA |
21 |
0.0015 |
| 250 |
ABSCESS NECK |
1 |
0.0015 |
| 251 |
OLIGURIA |
9 |
0.0014 |
| 252 |
RASH VESICULAR |
7 |
0.0014 |
| 253 |
SERUM SICKNESS |
4 |
0.0014 |
| 254 |
PROTHROMBIN TIME SHORTENED |
2 |
0.0014 |
| 255 |
NEUROTOXICITY |
25 |
0.0014 |
| 256 |
SEPTIC SHOCK |
62 |
0.0014 |
| 257 |
CULTURE URINE POSITIVE |
2 |
0.0014 |
| 258 |
RENAL TUBULAR DISORDER |
4 |
0.0014 |
| 259 |
VENOOCCLUSIVE LIVER DISEASE |
7 |
0.0014 |
| 260 |
BLOOD POTASSIUM INCREASED |
23 |
0.0014 |
| 261 |
SKIN WEEPING |
5 |
0.0014 |
| 262 |
ANTIBODY TEST ABNORMAL |
1 |
0.0014 |
| 263 |
ESCHERICHIA SEPSIS |
4 |
0.0014 |
| 264 |
BLOOD BILIRUBIN UNCONJUGATED INCREASED |
1 |
0.0014 |
| 265 |
GASTROINTESTINAL NECROSIS |
4 |
0.0014 |
| 266 |
B-CELL TYPE ACUTE LEUKAEMIA |
1 |
0.0014 |
| 267 |
NORMOCYTIC ANAEMIA |
2 |
0.0014 |
| 268 |
ACUTE MYELOID LEUKAEMIA |
21 |
0.0013 |
| 269 |
MUCOSAL INFLAMMATION |
35 |
0.0013 |
| 270 |
METABOLIC ENCEPHALOPATHY |
4 |
0.0013 |
| 271 |
SERUM FERRITIN INCREASED |
7 |
0.0013 |
| 272 |
RESPIRATORY FAILURE |
95 |
0.0013 |
| 273 |
ASPIRATION PLEURAL CAVITY |
1 |
0.0013 |
| 274 |
TOXIC SKIN ERUPTION |
13 |
0.0013 |
| 275 |
ONYCHOLYSIS |
2 |
0.0013 |
| 276 |
RESPIRATORY ACIDOSIS |
5 |
0.0013 |
| 277 |
BLOOD FIBRINOGEN INCREASED |
1 |
0.0013 |
| 278 |
PNEUMONIA FUNGAL |
5 |
0.0013 |
| 279 |
TOTAL LUNG CAPACITY DECREASED |
2 |
0.0013 |
| 280 |
AZOTAEMIA |
5 |
0.0013 |
| 281 |
IMMUNOSUPPRESSION |
11 |
0.0012 |
| 282 |
CYTOPENIA |
15 |
0.0012 |
| 283 |
HYPOGAMMAGLOBULINAEMIA |
8 |
0.0012 |
| 284 |
HYPOPHOSPHATAEMIA |
9 |
0.0012 |
| 285 |
ENCEPHALOPATHY |
29 |
0.0012 |
| 286 |
BACTERAEMIA |
14 |
0.0012 |
| 287 |
B-CELL LYMPHOMA |
4 |
0.0012 |
| 288 |
ESCHERICHIA URINARY TRACT INFECTION |
5 |
0.0012 |
| 289 |
ENTERITIS INFECTIOUS |
2 |
0.0012 |
| 290 |
CANCER PAIN |
3 |
0.0012 |
| 291 |
ANURIA |
10 |
0.0012 |
| 292 |
HAEMATOTOXICITY |
11 |
0.0012 |
| 293 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
11 |
0.0012 |
| 294 |
HYPERSENSITIVITY VASCULITIS |
3 |
0.0011 |
| 295 |
CLOSTRIDIUM DIFFICILE COLITIS |
12 |
0.0011 |
| 296 |
BLOOD POTASSIUM ABNORMAL |
3 |
0.0011 |
| 297 |
CANDIDA SEPSIS |
1 |
0.0011 |
| 298 |
VOCAL CORD PARALYSIS |
2 |
0.0011 |
| 299 |
BRUXISM |
6 |
0.0011 |
| 300 |
SUSPECTED OFF LABEL USE |
5 |
0.0011 |
| 301 |
SOFT TISSUE INFECTION |
2 |
0.0011 |
| 302 |
PANCYTOPENIA |
61 |
0.0011 |
| 303 |
BUNDLE BRANCH BLOCK RIGHT |
5 |
0.0011 |
| 304 |
PNEUMONIA KLEBSIELLA |
2 |
0.0011 |
| 305 |
PLEURITIC PAIN |
3 |
0.0011 |
| 306 |
PNEUMOPERITONEUM |
2 |
0.0011 |
| 307 |
PLASMACYTOMA |
2 |
0.0011 |
| 308 |
LUNG CONSOLIDATION |
3 |
0.0011 |
| 309 |
PRODUCT PREPARATION ISSUE |
7 |
0.0011 |
| 310 |
SMALL INTESTINAL PERFORATION |
2 |
0.0011 |
| 311 |
ASPERGILLUS INFECTION |
7 |
0.0011 |
| 312 |
BLOOD UREA ABNORMAL |
1 |
0.0011 |
| 313 |
INFECTED SKIN ULCER |
2 |
0.0011 |
| 314 |
FACIAL PARALYSIS |
9 |
0.0011 |
| 315 |
COR PULMONALE |
1 |
0.0010 |
| 316 |
ACIDOSIS |
8 |
0.0010 |
| 317 |
CARDIOGENIC SHOCK |
15 |
0.0010 |
| 318 |
MULTI-ORGAN FAILURE |
18 |
0.0010 |
| 319 |
BRONCHOPULMONARY ASPERGILLOSIS |
8 |
0.0010 |
| 320 |
HYPOALBUMINAEMIA |
8 |
0.0010 |
| 321 |
CYTOMEGALOVIRUS CHORIORETINITIS |
2 |
0.0010 |
| 322 |
ORAL INFECTION |
4 |
0.0010 |
| 323 |
LUNG INFILTRATION |
9 |
0.0010 |
| 324 |
OCCULT BLOOD POSITIVE |
2 |
0.0010 |
| 325 |
HYPERVOLAEMIA |
5 |
0.0010 |
| 326 |
GENE MUTATION |
2 |
0.0010 |
| 327 |
CELL DEATH |
2 |
0.0010 |
| 328 |
NEUTROPENIA |
137 |
0.0010 |
| 329 |
CANDIDA INFECTION |
17 |
0.0010 |
| 330 |
HYPERNATRAEMIA |
5 |
0.0010 |
| 331 |
MIXED LIVER INJURY |
3 |
0.0010 |
| 332 |
DEVICE RELATED SEPSIS |
2 |
0.0010 |
| 333 |
MUCOSAL DRYNESS |
2 |
0.0010 |
| 334 |
BONE MARROW FAILURE |
20 |
0.0010 |
| 335 |
DIVERTICULAR PERFORATION |
2 |
0.0010 |
| 336 |
ACUTE KIDNEY INJURY |
148 |
0.0010 |
| 337 |
ABSCESS JAW |
1 |
0.0010 |
| 338 |
PERIORBITAL OEDEMA |
5 |
0.0010 |
| 339 |
BLAST CELL COUNT INCREASED |
1 |
0.0010 |
| 340 |
NON-CARDIAC CHEST PAIN |
3 |
0.0009 |
| 341 |
ELECTROLYTE IMBALANCE |
11 |
0.0009 |
| 342 |
BLOOD SODIUM ABNORMAL |
1 |
0.0009 |
| 343 |
CEREBRAL ARTERY OCCLUSION |
1 |
0.0009 |
| 344 |
SEPSIS |
104 |
0.0009 |
| 345 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
2 |
0.0009 |
| 346 |
EXOPHTHALMOS |
2 |
0.0009 |
| 347 |
LYMPHOCYTOSIS |
2 |
0.0009 |
| 348 |
FACIAL PALSY |
2 |
0.0009 |
| 349 |
PERIODONTITIS |
2 |
0.0009 |
| 350 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
4 |
0.0009 |
| 351 |
LYMPHOCYTE COUNT INCREASED |
3 |
0.0009 |
| 352 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
8 |
0.0009 |
| 353 |
SINUS TACHYCARDIA |
13 |
0.0009 |
| 354 |
ACINETOBACTER INFECTION |
1 |
0.0009 |
| 355 |
PRODUCT PACKAGE ASSOCIATED INJURY |
2 |
0.0009 |
| 356 |
HEART RATE ABNORMAL |
5 |
0.0009 |
| 357 |
IRON DEFICIENCY |
4 |
0.0009 |
| 358 |
GRANULOCYTOPENIA |
5 |
0.0009 |
| 359 |
LEFT VENTRICULAR FAILURE |
3 |
0.0009 |
| 360 |
RESPIRATORY DISTRESS |
24 |
0.0009 |
| 361 |
CEREBRAL VENTRICLE DILATATION |
1 |
0.0009 |
| 362 |
ACUTE PRERENAL FAILURE |
1 |
0.0009 |
| 363 |
HAEMOLYTIC URAEMIC SYNDROME |
2 |
0.0009 |
| 364 |
AORTIC STENOSIS |
3 |
0.0009 |
| 365 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
2 |
0.0009 |
| 366 |
BILIRUBIN CONJUGATED INCREASED |
2 |
0.0009 |
| 367 |
PERIPHERAL SENSORY NEUROPATHY |
5 |
0.0009 |
| 368 |
ABNORMAL FAECES |
7 |
0.0009 |
| 369 |
COVID-19 PNEUMONIA |
10 |
0.0008 |
| 370 |
HYPOCALCAEMIA |
16 |
0.0008 |
| 371 |
METABOLIC ACIDOSIS |
27 |
0.0008 |
| 372 |
INTERCEPTED PRODUCT STORAGE ERROR |
3 |
0.0008 |
| 373 |
SUBDURAL HAEMATOMA |
12 |
0.0008 |
| 374 |
BONE LESION |
3 |
0.0008 |
| 375 |
HEPATITIS CHOLESTATIC |
5 |
0.0008 |
| 376 |
HEPATITIS B |
5 |
0.0008 |
| 377 |
HEPATIC FAILURE |
25 |
0.0008 |
| 378 |
ORAL INTAKE REDUCED |
2 |
0.0008 |
| 379 |
CLOSTRIDIUM COLITIS |
1 |
0.0008 |
| 380 |
PRODUCT PACKAGING CONFUSION |
2 |
0.0008 |
| 381 |
BLOOD CREATININE INCREASED |
53 |
0.0008 |
| 382 |
HEPATOTOXICITY |
18 |
0.0008 |
| 383 |
NERVOUS SYSTEM DISORDER |
25 |
0.0008 |
| 384 |
CATHETER SITE HAEMORRHAGE |
2 |
0.0008 |
| 385 |
CHRONIC SINUSITIS |
3 |
0.0008 |
| 386 |
METASTASES TO PERITONEUM |
2 |
0.0008 |
| 387 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
4 |
0.0008 |
| 388 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
3 |
0.0008 |
| 389 |
NEUTROPHIL COUNT DECREASED |
32 |
0.0008 |
| 390 |
BLOOD TEST ABNORMAL |
11 |
0.0008 |
| 391 |
HEPATOSPLENOMEGALY |
2 |
0.0008 |
| 392 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
4 |
0.0008 |
| 393 |
BENIGN PROSTATIC HYPERPLASIA |
4 |
0.0008 |
| 394 |
BILIARY OBSTRUCTION |
1 |
0.0008 |
| 395 |
VENTRICULAR DYSFUNCTION |
2 |
0.0008 |
| 396 |
CARDIOPULMONARY FAILURE |
3 |
0.0008 |
| 397 |
LUNG OPACITY |
2 |
0.0008 |
| 398 |
BACTERIAL INFECTION |
14 |
0.0007 |
| 399 |
ANION GAP INCREASED |
1 |
0.0007 |
| 400 |
ORGAN FAILURE |
3 |
0.0007 |
| 401 |
TACHYPNOEA |
10 |
0.0007 |
| 402 |
CHOLESTASIS |
14 |
0.0007 |
| 403 |
ACUTE RESPIRATORY FAILURE |
14 |
0.0007 |
| 404 |
ATELECTASIS |
7 |
0.0007 |
| 405 |
COAGULOPATHY |
12 |
0.0007 |
| 406 |
LEUKOPENIA |
36 |
0.0007 |
| 407 |
THROMBOCYTOPENIA |
80 |
0.0007 |
| 408 |
HAEMODIALYSIS |
6 |
0.0007 |
| 409 |
ACUTE PULMONARY OEDEMA |
4 |
0.0007 |
| 410 |
BLOOD CALCIUM DECREASED |
8 |
0.0007 |
| 411 |
BUNDLE BRANCH BLOCK LEFT |
3 |
0.0007 |
| 412 |
ATYPICAL MYCOBACTERIAL INFECTION |
1 |
0.0007 |
| 413 |
NECK MASS |
2 |
0.0007 |
| 414 |
RESPIRATORY SYMPTOM |
2 |
0.0007 |
| 415 |
TUBULOINTERSTITIAL NEPHRITIS |
13 |
0.0007 |
| 416 |
OCULAR ICTERUS |
3 |
0.0007 |
| 417 |
HAEMOTHORAX |
2 |
0.0007 |
| 418 |
SPLENOMEGALY |
8 |
0.0007 |
| 419 |
PRODUCT PREPARATION ERROR |
14 |
0.0007 |
| 420 |
CARDIAC FIBRILLATION |
1 |
0.0007 |
| 421 |
APRAXIA |
1 |
0.0007 |
| 422 |
ATYPICAL PNEUMONIA |
2 |
0.0007 |
| 423 |
CHROMATURIA |
15 |
0.0007 |
| 424 |
MYELOFIBROSIS |
2 |
0.0007 |
| 425 |
VASCULAR DEVICE INFECTION |
3 |
0.0007 |
| 426 |
PROSTATITIS |
2 |
0.0007 |
| 427 |
TROPONIN INCREASED |
5 |
0.0007 |
| 428 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
1 |
0.0007 |
| 429 |
HYPERTHERMIA |
5 |
0.0007 |
| 430 |
LUMBAR VERTEBRAL FRACTURE |
3 |
0.0007 |
| 431 |
INFUSION RELATED REACTION |
43 |
0.0006 |
| 432 |
DIASTOLIC DYSFUNCTION |
2 |
0.0006 |
| 433 |
APPENDICITIS |
6 |
0.0006 |
| 434 |
PULMONARY HAEMORRHAGE |
5 |
0.0006 |
| 435 |
ASPIRATION |
7 |
0.0006 |
| 436 |
BLOOD BILIRUBIN INCREASED |
17 |
0.0006 |
| 437 |
HYPOKALAEMIA |
29 |
0.0006 |
| 438 |
PNEUMONIA VIRAL |
2 |
0.0006 |
| 439 |
VENTRICULAR HYPOKINESIA |
2 |
0.0006 |
| 440 |
MYASTHENIA GRAVIS |
5 |
0.0006 |
| 441 |
HEPATITIS ACUTE |
4 |
0.0006 |
| 442 |
RENAL TUBULAR NECROSIS |
6 |
0.0006 |
| 443 |
RENAL FAILURE |
81 |
0.0006 |
| 444 |
DEAFNESS NEUROSENSORY |
2 |
0.0006 |
| 445 |
CYTOLYTIC HEPATITIS |
2 |
0.0006 |
| 446 |
PRODUCT PRESCRIBING ISSUE |
13 |
0.0006 |
| 447 |
CLOSTRIDIUM DIFFICILE INFECTION |
13 |
0.0006 |
| 448 |
PERICARDITIS |
10 |
0.0006 |
| 449 |
KLEBSIELLA INFECTION |
3 |
0.0006 |
| 450 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
13 |
0.0006 |
| 451 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
3 |
0.0006 |
| 452 |
BLOOD PH DECREASED |
1 |
0.0006 |
| 453 |
TRANSAMINASES INCREASED |
13 |
0.0006 |
| 454 |
BLOOD AMYLASE INCREASED |
1 |
0.0006 |
| 455 |
DRUG RESISTANCE |
15 |
0.0006 |
| 456 |
C-REACTIVE PROTEIN INCREASED |
21 |
0.0006 |
| 457 |
STAPHYLOCOCCAL INFECTION |
19 |
0.0006 |
| 458 |
PLEURAL EFFUSION |
35 |
0.0006 |
| 459 |
HYPERTRANSAMINASAEMIA |
4 |
0.0006 |
| 460 |
PETECHIAE |
6 |
0.0006 |
| 461 |
HYPOMAGNESAEMIA |
8 |
0.0006 |
| 462 |
CARDIO-RESPIRATORY ARREST |
24 |
0.0006 |
| 463 |
THROMBOPHLEBITIS |
2 |
0.0006 |
| 464 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
2 |
0.0006 |
| 465 |
LYMPHOCYTE COUNT DECREASED |
10 |
0.0006 |
| 466 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
10 |
0.0006 |
| 467 |
RESPIRATORY RATE INCREASED |
5 |
0.0006 |
| 468 |
APHASIA |
17 |
0.0006 |
| 469 |
ANAL FISSURE |
3 |
0.0006 |
| 470 |
FLUID OVERLOAD |
8 |
0.0005 |
| 471 |
BLOOD PHOSPHORUS DECREASED |
2 |
0.0005 |
| 472 |
RENAL FAILURE ACUTE |
23 |
0.0005 |
| 473 |
SKIN DISORDER |
18 |
0.0005 |
| 474 |
BLOOD UREA INCREASED |
9 |
0.0005 |
| 475 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
9 |
0.0005 |
| 476 |
PULMONARY ALVEOLAR HAEMORRHAGE |
3 |
0.0005 |
| 477 |
HYPONATRAEMIA |
30 |
0.0005 |
| 478 |
ORAL CANDIDIASIS |
7 |
0.0005 |
| 479 |
SKIN TOXICITY |
3 |
0.0005 |
| 480 |
CIRCULATORY COLLAPSE |
9 |
0.0005 |
| 481 |
BONE MARROW TRANSPLANT |
1 |
0.0005 |
| 482 |
BILE DUCT OBSTRUCTION |
1 |
0.0005 |
| 483 |
ALANINE AMINOTRANSFERASE INCREASED |
32 |
0.0005 |
| 484 |
SINUS BRADYCARDIA |
5 |
0.0005 |
| 485 |
RALES |
3 |
0.0005 |
| 486 |
REHABILITATION THERAPY |
2 |
0.0005 |
| 487 |
PRODUCT LABEL CONFUSION |
3 |
0.0005 |
| 488 |
SPINAL CORD COMPRESSION |
2 |
0.0005 |
| 489 |
PLASMA CELL MYELOMA |
20 |
0.0005 |
| 490 |
ABDOMINAL WALL HAEMATOMA |
1 |
0.0005 |
| 491 |
ASCITES |
15 |
0.0005 |
| 492 |
BICYTOPENIA |
1 |
0.0005 |
| 493 |
ANAEMIA |
96 |
0.0005 |
| 494 |
OESOPHAGEAL CANDIDIASIS |
2 |
0.0005 |
| 495 |
PROTHROMBIN TIME PROLONGED |
3 |
0.0005 |
| 496 |
GOUT |
9 |
0.0005 |
| 497 |
POLYNEUROPATHY |
6 |
0.0005 |
| 498 |
SKIN PAPILLOMA |
2 |
0.0005 |
| 499 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
5 |
0.0005 |
| 500 |
LEUKOCYTOSIS |
9 |
0.0005 |
| 501 |
CARDIAC ARREST |
41 |
0.0005 |
| 502 |
DIALYSIS |
7 |
0.0005 |
| 503 |
WHITE BLOOD CELL COUNT DECREASED |
53 |
0.0005 |
| 504 |
EXTRAVASATION |
2 |
0.0005 |
| 505 |
ESCHERICHIA INFECTION |
4 |
0.0005 |
| 506 |
ANAPHYLACTOID REACTION |
2 |
0.0005 |
| 507 |
VENTRICULAR TACHYCARDIA |
8 |
0.0005 |
| 508 |
ACUTE CORONARY SYNDROME |
4 |
0.0005 |
| 509 |
ILEUS |
6 |
0.0005 |
| 510 |
CYTOMEGALOVIRUS INFECTION |
8 |
0.0005 |
| 511 |
GASTROINTESTINAL PERFORATION |
2 |
0.0005 |
| 512 |
SHOCK |
11 |
0.0005 |
| 513 |
FOLLICULITIS |
5 |
0.0005 |
| 514 |
GENERAL PHYSICAL HEALTH DETERIORATION |
55 |
0.0005 |
| 515 |
ALANINE AMINOTRANSFERASE ABNORMAL |
1 |
0.0005 |
| 516 |
ENTERITIS |
3 |
0.0005 |
| 517 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
3 |
0.0005 |
| 518 |
UNRESPONSIVE TO STIMULI |
12 |
0.0005 |
| 519 |
DISEASE PROGRESSION |
55 |
0.0005 |
| 520 |
DELIRIUM |
16 |
0.0005 |
| 521 |
PULMONARY CONGESTION |
6 |
0.0005 |
| 522 |
PARONYCHIA |
2 |
0.0005 |
| 523 |
DEVICE RELATED INFECTION |
7 |
0.0005 |
| 524 |
CLOSTRIDIUM TEST POSITIVE |
1 |
0.0005 |
| 525 |
LUNG INFECTION |
7 |
0.0005 |
| 526 |
CARDIAC FAILURE ACUTE |
3 |
0.0004 |
| 527 |
OBSTRUCTIVE AIRWAYS DISORDER |
5 |
0.0004 |
| 528 |
HYPOTENSION |
90 |
0.0004 |
| 529 |
BACTERIAL TEST POSITIVE |
1 |
0.0004 |
| 530 |
LEFT VENTRICULAR DYSFUNCTION |
3 |
0.0004 |
| 531 |
CALCINOSIS |
1 |
0.0004 |
| 532 |
BRONCHIECTASIS |
3 |
0.0004 |
| 533 |
ULCER |
7 |
0.0004 |
| 534 |
HAEMATEMESIS |
11 |
0.0004 |
| 535 |
APHTHOUS STOMATITIS |
1 |
0.0004 |
| 536 |
CHRONIC MYELOID LEUKAEMIA |
2 |
0.0004 |
| 537 |
LOCALISED OEDEMA |
2 |
0.0004 |
| 538 |
OXYGEN SATURATION DECREASED |
24 |
0.0004 |
| 539 |
PYREXIA |
147 |
0.0004 |
| 540 |
CARDIAC TAMPONADE |
2 |
0.0004 |
| 541 |
HYPERLIPIDAEMIA |
5 |
0.0004 |
| 542 |
DERMATITIS BULLOUS |
3 |
0.0004 |
| 543 |
MOUTH HAEMORRHAGE |
3 |
0.0004 |
| 544 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
7 |
0.0004 |
| 545 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0004 |
| 546 |
BREATH SOUNDS ABNORMAL |
2 |
0.0004 |
| 547 |
STAPHYLOCOCCAL SEPSIS |
2 |
0.0004 |
| 548 |
HOSPICE CARE |
4 |
0.0004 |
| 549 |
STEVENS-JOHNSON SYNDROME |
9 |
0.0004 |
| 550 |
PNEUMONITIS |
11 |
0.0004 |
| 551 |
INFLAMMATORY MARKER INCREASED |
2 |
0.0004 |
| 552 |
PLATELET COUNT DECREASED |
43 |
0.0004 |
| 553 |
ABDOMINAL TENDERNESS |
2 |
0.0004 |
| 554 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
22 |
0.0004 |
| 555 |
PNEUMONIA ASPIRATION |
10 |
0.0004 |
| 556 |
BRAIN OEDEMA |
5 |
0.0004 |
| 557 |
RENAL IMPAIRMENT |
33 |
0.0004 |
| 558 |
SUBARACHNOID HAEMORRHAGE |
4 |
0.0004 |
| 559 |
AORTIC ARTERIOSCLEROSIS |
1 |
0.0004 |
| 560 |
CARDIAC FAILURE |
31 |
0.0004 |
| 561 |
ACTINIC KERATOSIS |
1 |
0.0004 |
| 562 |
VENTRICULAR EXTRASYSTOLES |
4 |
0.0004 |
| 563 |
COMPARTMENT SYNDROME |
1 |
0.0004 |
| 564 |
DRUG-INDUCED LIVER INJURY |
12 |
0.0004 |
| 565 |
ARRHYTHMIA |
18 |
0.0004 |
| 566 |
AGRANULOCYTOSIS |
7 |
0.0004 |
| 567 |
ASPARTATE AMINOTRANSFERASE INCREASED |
20 |
0.0004 |
| 568 |
ATRIAL FLUTTER |
3 |
0.0004 |
| 569 |
ANAL FISTULA |
2 |
0.0004 |
| 570 |
AREFLEXIA |
1 |
0.0004 |
| 571 |
LIVER FUNCTION TEST INCREASED |
8 |
0.0004 |
| 572 |
RHINITIS |
3 |
0.0004 |
| 573 |
JAUNDICE |
10 |
0.0004 |
| 574 |
SHOCK HAEMORRHAGIC |
3 |
0.0004 |
| 575 |
DECUBITUS ULCER |
3 |
0.0004 |
| 576 |
SKIN LACERATION |
4 |
0.0004 |
| 577 |
CLUMSINESS |
1 |
0.0004 |
| 578 |
WHITE BLOOD CELL COUNT INCREASED |
14 |
0.0004 |
| 579 |
INTESTINAL ISCHAEMIA |
2 |
0.0004 |
| 580 |
ELECTROCARDIOGRAM QT PROLONGED |
13 |
0.0004 |
| 581 |
EMBOLISM |
3 |
0.0004 |
| 582 |
GASTRIC ULCER HAEMORRHAGE |
2 |
0.0004 |
| 583 |
MENTAL STATUS CHANGES |
10 |
0.0004 |
| 584 |
ANGIOPATHY |
2 |
0.0004 |
| 585 |
REBOUND EFFECT |
4 |
0.0004 |
| 586 |
CEREBRAL THROMBOSIS |
1 |
0.0004 |
| 587 |
HAEMATOCRIT DECREASED |
7 |
0.0004 |
| 588 |
PERONEAL NERVE PALSY |
2 |
0.0004 |
| 589 |
NEUTROPHILIA |
2 |
0.0004 |
| 590 |
HAEMATURIA |
12 |
0.0004 |
| 591 |
HEPATIC FUNCTION ABNORMAL |
13 |
0.0003 |
| 592 |
BLOOD MAGNESIUM DECREASED |
3 |
0.0003 |
| 593 |
FULL BLOOD COUNT DECREASED |
7 |
0.0003 |
| 594 |
MYOPATHY |
3 |
0.0003 |
| 595 |
NEOPLASM PROGRESSION |
12 |
0.0003 |
| 596 |
URINE OUTPUT DECREASED |
3 |
0.0003 |
| 597 |
BLOOD CALCIUM INCREASED |
3 |
0.0003 |
| 598 |
CARDIOMYOPATHY |
5 |
0.0003 |
| 599 |
GLUCOSE TOLERANCE IMPAIRED |
2 |
0.0003 |
| 600 |
CREPITATIONS |
1 |
0.0003 |
| 601 |
BLOOD CULTURE POSITIVE |
1 |
0.0003 |
| 602 |
MYELOSUPPRESSION |
12 |
0.0003 |
| 603 |
CENTRAL VENOUS CATHETERISATION |
1 |
0.0003 |
| 604 |
SQUAMOUS CELL CARCINOMA OF SKIN |
2 |
0.0003 |
| 605 |
FUNGAL INFECTION |
11 |
0.0003 |
| 606 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
1 |
0.0003 |
| 607 |
NEURALGIA |
8 |
0.0003 |
| 608 |
RETCHING |
7 |
0.0003 |
| 609 |
CHEST X-RAY ABNORMAL |
1 |
0.0003 |
| 610 |
SMALL INTESTINAL OBSTRUCTION |
4 |
0.0003 |
| 611 |
HAEMOPTYSIS |
9 |
0.0003 |
| 612 |
EPSTEIN-BARR VIRUS INFECTION |
2 |
0.0003 |
| 613 |
BLOOD BLISTER |
1 |
0.0003 |
| 614 |
BLOOD CREATININE DECREASED |
1 |
0.0003 |
| 615 |
ATRIAL FIBRILLATION |
31 |
0.0003 |
| 616 |
COLITIS |
12 |
0.0003 |
| 617 |
RASH MACULO-PAPULAR |
7 |
0.0003 |
| 618 |
WHITE BLOOD CELL COUNT ABNORMAL |
2 |
0.0003 |
| 619 |
SUPRAVENTRICULAR TACHYCARDIA |
3 |
0.0003 |
| 620 |
PULMONARY OEDEMA |
14 |
0.0003 |
| 621 |
LYMPHADENOPATHY |
11 |
0.0003 |
| 622 |
HYPERCHOLESTEROLAEMIA |
3 |
0.0003 |
| 623 |
CORONAVIRUS INFECTION |
2 |
0.0003 |
| 624 |
RESPIRATORY DISORDER |
9 |
0.0003 |
| 625 |
HYPOTONIA |
3 |
0.0003 |
| 626 |
TERMINAL STATE |
2 |
0.0003 |
| 627 |
CLOSTRIDIAL INFECTION |
1 |
0.0003 |
| 628 |
OEDEMA |
16 |
0.0003 |
| 629 |
GENERAL PHYSICAL CONDITION ABNORMAL |
2 |
0.0003 |
| 630 |
BODY TEMPERATURE INCREASED |
6 |
0.0003 |
| 631 |
TACHYCARDIA |
26 |
0.0003 |
| 632 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
3 |
0.0003 |
| 633 |
BRONCHOPNEUMONIA |
1 |
0.0003 |
| 634 |
PERIPHERAL COLDNESS |
4 |
0.0003 |
| 635 |
APLASIA PURE RED CELL |
1 |
0.0003 |
| 636 |
RESPIRATORY ARREST |
8 |
0.0003 |
| 637 |
CERVICAL VERTEBRAL FRACTURE |
1 |
0.0003 |
| 638 |
BLOOD CREATININE ABNORMAL |
1 |
0.0003 |
| 639 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
7 |
0.0003 |
| 640 |
PARALYSIS |
4 |
0.0003 |
| 641 |
LACTIC ACIDOSIS |
9 |
0.0003 |
| 642 |
CELLULITIS |
14 |
0.0003 |
| 643 |
CHRONIC GRAFT VERSUS HOST DISEASE |
1 |
0.0003 |
| 644 |
MYELODYSPLASTIC SYNDROME |
4 |
0.0003 |
| 645 |
INFECTION |
40 |
0.0003 |
| 646 |
LIVER FUNCTION TEST ABNORMAL |
8 |
0.0003 |
| 647 |
MELAENA |
6 |
0.0003 |
| 648 |
HYPERTENSIVE CRISIS |
3 |
0.0003 |
| 649 |
PULMONARY MASS |
4 |
0.0003 |
| 650 |
HAEMORRHAGE INTRACRANIAL |
4 |
0.0003 |
| 651 |
NEPHROPATHY TOXIC |
3 |
0.0003 |
| 652 |
HYDRONEPHROSIS |
2 |
0.0003 |
| 653 |
MITRAL VALVE INCOMPETENCE |
3 |
0.0003 |
| 654 |
CHEMOTHERAPY |
1 |
0.0003 |
| 655 |
CONJUNCTIVAL HAEMORRHAGE |
1 |
0.0003 |
| 656 |
NEPHROLITHIASIS |
12 |
0.0003 |
| 657 |
CLAVICLE FRACTURE |
1 |
0.0003 |
| 658 |
LIPASE INCREASED |
2 |
0.0003 |
| 659 |
NEOPLASM |
3 |
0.0003 |
| 660 |
LYMPHOMA |
4 |
0.0003 |
| 661 |
APHTHOUS ULCER |
2 |
0.0003 |
| 662 |
EJECTION FRACTION DECREASED |
4 |
0.0003 |
| 663 |
APNOEA |
2 |
0.0003 |
| 664 |
HEART RATE DECREASED |
9 |
0.0003 |
| 665 |
BONE PAIN |
15 |
0.0003 |
| 666 |
ELECTROCARDIOGRAM ABNORMAL |
2 |
0.0003 |
| 667 |
PNEUMONIA |
82 |
0.0003 |
| 668 |
CYSTITIS |
8 |
0.0003 |
| 669 |
CEREBRAL ATROPHY |
1 |
0.0003 |
| 670 |
PRESCRIBED UNDERDOSE |
5 |
0.0003 |
| 671 |
ARTERIOSPASM CORONARY |
1 |
0.0002 |
| 672 |
MUSCLE DISORDER |
2 |
0.0002 |
| 673 |
OFF LABEL USE |
216 |
0.0002 |
| 674 |
ANGINA PECTORIS |
7 |
0.0002 |
| 675 |
SECOND PRIMARY MALIGNANCY |
2 |
0.0002 |
| 676 |
HEMIPLEGIA |
2 |
0.0002 |
| 677 |
RASH PRURITIC |
13 |
0.0002 |
| 678 |
DERMATITIS ALLERGIC |
3 |
0.0002 |
| 679 |
MOUTH ULCERATION |
5 |
0.0002 |
| 680 |
FACE OEDEMA |
4 |
0.0002 |
| 681 |
FLUID RETENTION |
12 |
0.0002 |
| 682 |
MALIGNANT NEOPLASM PROGRESSION |
24 |
0.0002 |
| 683 |
LACRIMATION INCREASED |
7 |
0.0002 |
| 684 |
HYSTERECTOMY |
2 |
0.0002 |
| 685 |
RESPIRATORY TRACT INFECTION |
6 |
0.0002 |
| 686 |
RASH ERYTHEMATOUS |
11 |
0.0002 |
| 687 |
ABDOMINAL DISTENSION |
24 |
0.0002 |
| 688 |
NODULE |
3 |
0.0002 |
| 689 |
OEDEMA PERIPHERAL |
28 |
0.0002 |
| 690 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
9 |
0.0002 |
| 691 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 692 |
CONFUSIONAL STATE |
36 |
0.0002 |
| 693 |
THERAPY NON-RESPONDER |
10 |
0.0002 |
| 694 |
HYPERGLYCAEMIA |
8 |
0.0002 |
| 695 |
ACUTE HEPATIC FAILURE |
3 |
0.0002 |
| 696 |
END STAGE RENAL DISEASE |
4 |
0.0002 |
| 697 |
ACUTE GRAFT VERSUS HOST DISEASE |
1 |
0.0002 |
| 698 |
PNEUMONIA BACTERIAL |
2 |
0.0002 |
| 699 |
BRAIN NEOPLASM |
2 |
0.0002 |
| 700 |
PERICARDIAL EFFUSION |
5 |
0.0002 |
| 701 |
CONJUNCTIVITIS |
4 |
0.0002 |
| 702 |
HEPATIC ENCEPHALOPATHY |
2 |
0.0002 |
| 703 |
CHILLS |
25 |
0.0002 |
| 704 |
HEPATIC CIRRHOSIS |
4 |
0.0002 |
| 705 |
DYSARTHRIA |
8 |
0.0002 |
| 706 |
SQUAMOUS CELL CARCINOMA |
2 |
0.0002 |
| 707 |
LEUKAEMIA |
2 |
0.0002 |
| 708 |
SPUTUM DISCOLOURED |
2 |
0.0002 |
| 709 |
PRODUCT PACKAGING ISSUE |
2 |
0.0002 |
| 710 |
VIRAL INFECTION |
7 |
0.0002 |
| 711 |
BRONCHOSPASM |
3 |
0.0002 |
| 712 |
RED BLOOD CELL COUNT DECREASED |
6 |
0.0002 |
| 713 |
BRADYCARDIA |
11 |
0.0002 |
| 714 |
AUTOIMMUNE DISORDER |
2 |
0.0002 |
| 715 |
HAEMOGLOBIN DECREASED |
21 |
0.0002 |
| 716 |
DISORIENTATION |
8 |
0.0002 |
| 717 |
CONDITION AGGRAVATED |
61 |
0.0002 |
| 718 |
CORONARY ARTERY DISEASE |
6 |
0.0002 |
| 719 |
AMMONIA INCREASED |
1 |
0.0002 |
| 720 |
CACHEXIA |
1 |
0.0002 |
| 721 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
5 |
0.0002 |
| 722 |
ANKLE FRACTURE |
3 |
0.0002 |
| 723 |
RENAL DISORDER |
9 |
0.0002 |
| 724 |
PERITONITIS |
4 |
0.0002 |
| 725 |
PULMONARY HYPERTENSION |
4 |
0.0002 |
| 726 |
APLASTIC ANAEMIA |
1 |
0.0002 |
| 727 |
GASTROINTESTINAL HAEMORRHAGE |
16 |
0.0002 |
| 728 |
TRANSFUSION |
2 |
0.0002 |
| 729 |
CYANOSIS |
3 |
0.0002 |
| 730 |
FULL BLOOD COUNT ABNORMAL |
2 |
0.0002 |
| 731 |
COMPRESSION FRACTURE |
1 |
0.0002 |
| 732 |
PRODUCT USE IN UNAPPROVED INDICATION |
46 |
0.0002 |
| 733 |
ANAL ABSCESS |
1 |
0.0002 |
| 734 |
MULTIPLE FRACTURES |
3 |
0.0002 |
| 735 |
STOMATITIS |
11 |
0.0002 |
| 736 |
ANAPHYLACTIC REACTION |
10 |
0.0002 |
| 737 |
MEDICATION ERROR |
10 |
0.0002 |
| 738 |
PULMONARY EMBOLISM |
17 |
0.0002 |
| 739 |
MALNUTRITION |
2 |
0.0002 |
| 740 |
INTESTINAL PERFORATION |
2 |
0.0002 |
| 741 |
BLISTER |
10 |
0.0002 |
| 742 |
HEMIPARESIS |
3 |
0.0002 |
| 743 |
STATUS EPILEPTICUS |
2 |
0.0002 |
| 744 |
CHOLECYSTITIS ACUTE |
1 |
0.0002 |
| 745 |
MICTURITION URGENCY |
2 |
0.0002 |
| 746 |
EPISTAXIS |
13 |
0.0002 |
| 747 |
UPPER RESPIRATORY TRACT INFECTION |
8 |
0.0002 |
| 748 |
DEHYDRATION |
23 |
0.0002 |
| 749 |
EYELID OEDEMA |
2 |
0.0002 |
| 750 |
PANCREATITIS |
9 |
0.0002 |
| 751 |
ACUTE MYOCARDIAL INFARCTION |
5 |
0.0002 |
| 752 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
12 |
0.0002 |
| 753 |
ISCHAEMIC STROKE |
3 |
0.0002 |
| 754 |
CARDIAC PACEMAKER INSERTION |
1 |
0.0002 |
| 755 |
SYNOVITIS |
3 |
0.0002 |
| 756 |
CONTRAINDICATED PRODUCT ADMINISTERED |
5 |
0.0002 |
| 757 |
NO THERAPEUTIC RESPONSE |
2 |
0.0002 |
| 758 |
LIVER INJURY |
4 |
0.0002 |
| 759 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
0.0002 |
| 760 |
CHOLANGITIS |
1 |
0.0002 |
| 761 |
CYST |
2 |
0.0002 |
| 762 |
HEPATIC STEATOSIS |
3 |
0.0002 |
| 763 |
CONSTIPATION |
35 |
0.0002 |
| 764 |
FLATULENCE |
9 |
0.0002 |
| 765 |
BLOOD URINE PRESENT |
3 |
0.0002 |
| 766 |
GASTRIC ULCER |
3 |
0.0002 |
| 767 |
CARDIOVASCULAR DISORDER |
4 |
0.0002 |
| 768 |
HEPATIC CYTOLYSIS |
2 |
0.0002 |
| 769 |
INTRAOCULAR PRESSURE INCREASED |
2 |
0.0002 |
| 770 |
HEPATITIS |
4 |
0.0002 |
| 771 |
VOMITING |
72 |
0.0002 |
| 772 |
DEAFNESS |
4 |
0.0002 |
| 773 |
TOOTH INFECTION |
2 |
0.0002 |
| 774 |
ARTERIOSCLEROSIS CORONARY ARTERY |
1 |
0.0002 |
| 775 |
SOMNOLENCE |
30 |
0.0001 |
| 776 |
PRODUCT STORAGE ERROR |
13 |
0.0001 |
| 777 |
CEREBROVASCULAR ACCIDENT |
25 |
0.0001 |
| 778 |
NEUROPATHY PERIPHERAL |
14 |
0.0001 |
| 779 |
DRUG TOXICITY |
2 |
0.0001 |
| 780 |
ABNORMAL LOSS OF WEIGHT |
1 |
0.0001 |
| 781 |
SKIN LESION |
4 |
0.0001 |
| 782 |
SKIN REACTION |
2 |
0.0001 |
| 783 |
PRODUCT DISPENSING ERROR |
3 |
0.0001 |
| 784 |
INTERVERTEBRAL DISC PROTRUSION |
3 |
0.0001 |
| 785 |
BLINDNESS TRANSIENT |
1 |
0.0001 |
| 786 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 787 |
SKIN HAEMORRHAGE |
2 |
0.0001 |
| 788 |
DYSPNOEA |
76 |
0.0001 |
| 789 |
ORAL PAIN |
3 |
0.0001 |
| 790 |
HEPATIC ENZYME INCREASED |
9 |
0.0001 |
| 791 |
SKIN DISCOLOURATION |
6 |
0.0001 |
| 792 |
SKIN EXFOLIATION |
11 |
0.0001 |
| 793 |
CHEST PAIN |
24 |
0.0001 |
| 794 |
BLOOD CHOLESTEROL INCREASED |
6 |
0.0001 |
| 795 |
THERAPY PARTIAL RESPONDER |
2 |
0.0001 |
| 796 |
HYPERTENSION |
27 |
0.0001 |
| 797 |
DISEASE RECURRENCE |
6 |
0.0001 |
| 798 |
THROMBOSIS |
10 |
0.0001 |
| 799 |
HYPOGLYCAEMIA |
6 |
0.0001 |
| 800 |
FOETAL EXPOSURE DURING PREGNANCY |
10 |
0.0001 |
| 801 |
ASPHYXIA |
1 |
0.0001 |
| 802 |
LUNG DISORDER |
6 |
0.0001 |
| 803 |
TREMOR |
20 |
0.0001 |
| 804 |
URINARY RETENTION |
4 |
0.0001 |
| 805 |
TRANSIENT ISCHAEMIC ATTACK |
4 |
0.0001 |
| 806 |
HYPOPHAGIA |
3 |
0.0001 |
| 807 |
PRODUCT USE ISSUE |
22 |
0.0001 |
| 808 |
INFLUENZA |
13 |
0.0001 |
| 809 |
HAEMATOMA |
3 |
0.0001 |
| 810 |
MENTAL DISORDER |
5 |
0.0001 |
| 811 |
SEDATION |
3 |
0.0001 |
| 812 |
COLD SWEAT |
2 |
0.0001 |
| 813 |
BLOOD TRIGLYCERIDES INCREASED |
2 |
0.0001 |
| 814 |
LIVER DISORDER |
5 |
0.0001 |
| 815 |
CARDIOTOXICITY |
1 |
0.0001 |
| 816 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 817 |
COVID-19 |
19 |
0.0001 |
| 818 |
FLUSHING |
11 |
0.0001 |
| 819 |
DECREASED APPETITE |
25 |
0.0001 |
| 820 |
ABDOMINAL PAIN |
25 |
0.0001 |
| 821 |
DEMENTIA |
3 |
0.0001 |
| 822 |
DRUG INEFFECTIVE |
140 |
0.0001 |
| 823 |
ABORTION INDUCED |
1 |
0.0001 |
| 824 |
DYSPNOEA EXERTIONAL |
4 |
0.0001 |
| 825 |
DYSPHAGIA |
10 |
0.0001 |
| 826 |
HAEMORRHAGE |
11 |
0.0001 |
| 827 |
PROTEINURIA |
2 |
0.0001 |
| 828 |
MUSCULOSKELETAL DISORDER |
2 |
0.0001 |
| 829 |
DIABETES MELLITUS |
8 |
0.0001 |
| 830 |
HERPES ZOSTER |
6 |
0.0001 |
| 831 |
PULMONARY FIBROSIS |
2 |
0.0001 |
| 832 |
WHEEZING |
6 |
0.0001 |
| 833 |
ASTHENIA |
38 |
0.0001 |
| 834 |
ABNORMAL BEHAVIOUR |
4 |
0.0001 |
| 835 |
BLOOD POTASSIUM DECREASED |
3 |
0.0001 |
| 836 |
CHEST DISCOMFORT |
10 |
0.0001 |
| 837 |
ACCIDENTAL EXPOSURE TO PRODUCT |
10 |
0.0001 |
| 838 |
AGITATION |
7 |
0.0001 |
| 839 |
BRONCHITIS |
7 |
0.0001 |
| 840 |
DIARRHOEA |
61 |
0.0001 |
| 841 |
JOINT INJURY |
2 |
0.0001 |
| 842 |
SKIN CANCER |
2 |
0.0001 |
| 843 |
COUGH |
26 |
0.0001 |
| 844 |
BALANCE DISORDER |
8 |
0.0001 |
| 845 |
DEEP VEIN THROMBOSIS |
6 |
0.0001 |
| 846 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 847 |
FAECES DISCOLOURED |
2 |
0.0001 |
| 848 |
NAUSEA |
73 |
0.0001 |
| 849 |
INTENTIONAL PRODUCT MISUSE |
8 |
0.0001 |
| 850 |
IMPAIRED HEALING |
3 |
0.0001 |
| 851 |
DEATH |
78 |
0.0001 |
| 852 |
SYNCOPE |
9 |
0.0001 |
| 853 |
GASTROINTESTINAL DISORDER |
8 |
0.0001 |
| 854 |
PANCREATITIS ACUTE |
2 |
0.0001 |
| 855 |
HEART RATE IRREGULAR |
2 |
0.0001 |
| 856 |
URINARY TRACT INFECTION |
15 |
0.0001 |
| 857 |
CONVULSION |
5 |
0.0001 |
| 858 |
LETHARGY |
5 |
0.0001 |
| 859 |
MUSCLE TWITCHING |
2 |
0.0001 |
| 860 |
DRY MOUTH |
7 |
0.0001 |
| 861 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
2 |
0.0001 |
| 862 |
SWELLING |
8 |
0.0001 |
| 863 |
ATAXIA |
1 |
0.0001 |
| 864 |
CHOLECYSTITIS |
1 |
0.0001 |
| 865 |
MENTAL IMPAIRMENT |
2 |
0.0001 |
| 866 |
CEREBRAL INFARCTION |
2 |
0.0001 |
| 867 |
MUSCULAR WEAKNESS |
9 |
0.0001 |
| 868 |
SEIZURE |
9 |
0.0001 |
| 869 |
ANAPHYLACTIC SHOCK |
2 |
0.0001 |
| 870 |
INFLAMMATION |
4 |
0.0001 |
| 871 |
SKIN ULCER |
2 |
0.0001 |
| 872 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
4 |
0.0001 |
| 873 |
LIMB INJURY |
2 |
0.0001 |
| 874 |
PALLOR |
2 |
0.0001 |
| 875 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
| 876 |
DRUG INTOLERANCE |
7 |
0.0001 |
| 877 |
TREATMENT FAILURE |
6 |
0.0001 |
| 878 |
CARPAL TUNNEL SYNDROME |
1 |
0.0001 |
| 879 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 880 |
LOSS OF CONSCIOUSNESS |
9 |
0.0001 |
| 881 |
INTERNATIONAL NORMALISED RATIO INCREASED |
2 |
0.0001 |
| 882 |
INCORRECT DOSE ADMINISTERED |
16 |
0.0001 |
| 883 |
SKIN BURNING SENSATION |
5 |
0.0001 |
| 884 |
DRUG INTERACTION |
11 |
0.0001 |
| 885 |
DYSSTASIA |
2 |
0.0001 |
| 886 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0001 |
| 887 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 888 |
URINARY INCONTINENCE |
2 |
0.0001 |
| 889 |
LOWER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 890 |
CHRONIC KIDNEY DISEASE |
5 |
0.0001 |
| 891 |
BLOOD PRESSURE INCREASED |
10 |
0.0001 |
| 892 |
DRUG ADMINISTRATION ERROR |
2 |
0.0001 |
| 893 |
HYPERSENSITIVITY |
12 |
0.0001 |
| 894 |
PRODUCTIVE COUGH |
3 |
0.0001 |
| 895 |
ABSCESS |
1 |
0.0001 |
| 896 |
HYPERHIDROSIS |
8 |
0.0001 |
| 897 |
NIGHT SWEATS |
2 |
0.0001 |
| 898 |
RASH |
27 |
0.0001 |
| 899 |
RHINORRHOEA |
4 |
0.0001 |
| 900 |
EYE DISORDER |
2 |
0.0001 |
| 901 |
BACK PAIN |
14 |
0.0001 |
| 902 |
BLOOD PRESSURE DECREASED |
4 |
0.0001 |
| 903 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
2 |
0.0001 |
| 904 |
FATIGUE |
45 |
0.0001 |
| 905 |
MALAISE |
25 |
0.0001 |
| 906 |
SLEEP DISORDER |
4 |
0.0001 |
| 907 |
CEREBRAL HAEMORRHAGE |
2 |
0.0001 |
| 908 |
DYSURIA |
2 |
0.0001 |
| 909 |
BLOOD GLUCOSE ABNORMAL |
1 |
0.0001 |
| 910 |
ERYTHEMA |
11 |
0.0001 |
| 911 |
CARDIAC DISORDER |
5 |
0.0001 |
| 912 |
INTESTINAL OBSTRUCTION |
2 |
0.0001 |
| 913 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 914 |
PARAESTHESIA |
8 |
0.0001 |
| 915 |
CATARACT |
3 |
0.0001 |
| 916 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 917 |
WEIGHT DECREASED |
14 |
0.0001 |
| 918 |
DIZZINESS |
25 |
0.0001 |
| 919 |
CARDIAC FAILURE CONGESTIVE |
4 |
0.0000 |
| 920 |
GASTROOESOPHAGEAL REFLUX DISEASE |
4 |
0.0000 |
| 921 |
VERTIGO |
3 |
0.0000 |
| 922 |
DYSKINESIA |
2 |
0.0000 |
| 923 |
DISCOMFORT |
3 |
0.0000 |
| 924 |
ABDOMINAL PAIN UPPER |
10 |
0.0000 |
| 925 |
EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 926 |
FALL |
16 |
0.0000 |
| 927 |
TOXICITY TO VARIOUS AGENTS |
8 |
0.0000 |
| 928 |
PRODUCT DOSE OMISSION |
3 |
0.0000 |
| 929 |
MYOCARDIAL INFARCTION |
8 |
0.0000 |
| 930 |
ANGIOEDEMA |
2 |
0.0000 |
| 931 |
DRY SKIN |
6 |
0.0000 |
| 932 |
PRURITUS |
17 |
0.0000 |
| 933 |
ARTHRALGIA |
18 |
0.0000 |
| 934 |
COGNITIVE DISORDER |
2 |
0.0000 |
| 935 |
BURNING SENSATION |
3 |
0.0000 |
| 936 |
OCULAR HYPERAEMIA |
2 |
0.0000 |
| 937 |
CONTUSION |
4 |
0.0000 |
| 938 |
INTERSTITIAL LUNG DISEASE |
2 |
0.0000 |
| 939 |
UNDERDOSE |
3 |
0.0000 |
| 940 |
HEART RATE INCREASED |
4 |
0.0000 |
| 941 |
DRY EYE |
2 |
0.0000 |
| 942 |
AGGRESSION |
2 |
0.0000 |
| 943 |
HEADACHE |
25 |
0.0000 |
| 944 |
UNEVALUABLE EVENT |
3 |
0.0000 |
| 945 |
ILLNESS |
4 |
0.0000 |
| 946 |
ARTHRITIS |
3 |
0.0000 |
| 947 |
HAEMATOCHEZIA |
2 |
0.0000 |
| 948 |
PAIN |
22 |
0.0000 |
| 949 |
NECK PAIN |
2 |
0.0000 |
| 950 |
WEIGHT INCREASED |
8 |
0.0000 |
| 951 |
EYE PAIN |
2 |
0.0000 |
| 952 |
NASAL CONGESTION |
2 |
0.0000 |
| 953 |
ADVERSE DRUG REACTION |
3 |
0.0000 |
| 954 |
ILL-DEFINED DISORDER |
2 |
0.0000 |
| 955 |
HOSPITALISATION |
5 |
0.0000 |
| 956 |
PERIPHERAL SWELLING |
5 |
0.0000 |
| 957 |
OROPHARYNGEAL PAIN |
3 |
0.0000 |
| 958 |
VISUAL IMPAIRMENT |
4 |
0.0000 |
| 959 |
ANXIETY |
9 |
0.0000 |
| 960 |
PAIN IN EXTREMITY |
9 |
0.0000 |
| 961 |
CHOLELITHIASIS |
1 |
0.0000 |
| 962 |
DYSPEPSIA |
3 |
0.0000 |
| 963 |
VISION BLURRED |
4 |
0.0000 |
| 964 |
MEMORY IMPAIRMENT |
4 |
0.0000 |
| 965 |
INJURY |
2 |
0.0000 |
| 966 |
ASTHMA |
3 |
0.0000 |
| 967 |
HOT FLUSH |
2 |
0.0000 |
| 968 |
BLINDNESS |
1 |
0.0000 |
| 969 |
URTICARIA |
4 |
0.0000 |
| 970 |
ABDOMINAL DISCOMFORT |
4 |
0.0000 |
| 971 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 972 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 973 |
NO ADVERSE EVENT |
4 |
0.0000 |
| 974 |
ADVERSE EVENT |
2 |
0.0000 |
| 975 |
COMA |
1 |
0.0000 |
| 976 |
MIGRAINE |
2 |
0.0000 |
| 977 |
COLORECTAL CANCER |
1 |
0.0000 |
| 978 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 979 |
INSOMNIA |
5 |
0.0000 |
| 980 |
ARTHROPATHY |
1 |
0.0000 |
| 981 |
MYALGIA |
3 |
0.0000 |
| 982 |
PRODUCT DOSE OMISSION ISSUE |
5 |
0.0000 |
| 983 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0000 |
| 984 |
JOINT SWELLING |
2 |
0.0000 |
| 985 |
MUSCLE SPASMS |
3 |
0.0000 |
| 986 |
AMNESIA |
1 |
0.0000 |
| 987 |
ALOPECIA |
3 |
0.0000 |
| 988 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 989 |
OVERDOSE |
2 |
0.0000 |
| 990 |
DEPRESSION |
2 |
0.0000 |
| 991 |
FEELING ABNORMAL |
2 |
0.0000 |
| 992 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |